Moleculin Biotech, Inc. (MBRX)
6.63
-0.62
(-8.55%)
USD |
NASDAQ |
Dec 09, 16:00
5.79
-0.84
(-12.67%)
Pre-Market: 08:35
Moleculin Biotech Total Liabilities (Quarterly): 47.27M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 413.50M |
| Harvard Bioscience, Inc. | 63.92M |
| Intensity Therapeutics, Inc. | 2.363M |
| NovaBay Pharmaceuticals, Inc. | 1.853M |
| Palatin Technologies, Inc. | 8.218M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 20.35M |
| Shareholders Equity (Quarterly) | -26.92M |
| Debt to Equity Ratio | -0.0145 |
| Current Ratio | 1.388 |
| Net Debt Paydown Yield | 0.11% |